Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues

MJ Thun, SJ Henley, C Patrono - Journal of the National Cancer …, 2002 - academic.oup.com
Numerous experimental, epidemiologic, and clinical studies suggest that nonsteroidal anti-
inflammatory drugs (NSAIDs), particularly the highly selective cyclooxygenase (COX)-2 …

Many actions of cyclooxygenase‐2 in cellular dynamics and in cancer

Y Cao, SM Prescott - Journal of cellular physiology, 2002 - Wiley Online Library
Abstract Cyclooxygenase‐2 (COX‐2) is the inducible isoform of cyclooxygenase, the
enzyme that catalyzes the rate‐limiting step in prostaglandin synthesis from arachidonic …

Cyclooxygenase-2 Inhibition by Celecoxib Reduces Proliferation and Induces Apoptosis in Angiogenic Endothelial Cells in Vivo

KM Leahy, RL Ornberg, Y Wang, BS Zweifel, AT Koki… - Cancer research, 2002 - AACR
Abstract Cyclooxygenase-2 (COX-2) is expressed within neovascular structures that support
many human cancers. Inhibition of COX-2 by celecoxib delays tumor growth and metastasis …

Chemoprevention: an essential approach to controlling cancer

MB Sporn, N Suh - Nature Reviews Cancer, 2002 - nature.com
Mortality that results from the common forms of cancer is still unacceptably high. Despite
immense advances in the understanding of the mechanisms of carcinogenesis, in bringing …

COX-2: a target for colon cancer prevention

LJ Marnett, RN DuBois - Annual review of pharmacology and …, 2002 - annualreviews.org
▪ Abstract Disease prevention is one area that both public and governmental agencies
strongly support owing to its potential for an improved lifestyle and a reduction in health care …

Celecoxib: a specific COX-2 inhibitor with anticancer properties

AT Koki, JL Masferrer - Cancer control, 2002 - journals.sagepub.com
In addition to the well-established pathophysiological role that COX-2 plays in inflammation,
recent evidence implies that this isoform may also be involved in multiple biologic events …

COX-2 inhibitors in cancer treatment and prevention, a recent development

XC Xu - Anti-cancer drugs, 2002 - journals.lww.com
Epidemiological and experimental studies have demonstrated the effect of non-steroidal anti-
inflammatory drugs (NSAIDs) in the prevention of human cancers. NSAIDs block …

[HTML][HTML] Prostaglandin E2 induces hypoxia-inducible factor-1α stabilization and nuclear localization in a human prostate cancer cell line

XH Liu, A Kirschenbaum, M Lu, S Yao… - Journal of Biological …, 2002 - ASBMB
Hypoxia-induced up-regulation of vascular endothelial growth factor (VEGF) expression is a
critical event leading to tumor neovascularization. Hypoxia stimulates hypoxia-inducible …

Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2

MAC Sabino, JR Ghilardi, JLM Jongen, CP Keyser… - Cancer research, 2002 - AACR
More than half of all chronic cancer pain arises from metastases to bone, and bone cancer
pain is one of the most difficult of all persistent pain states to fully control. Several tumor …

Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency

DE Corpet, S Taché - Nutrition and cancer, 2002 - Taylor & Francis
Potential chemopreventive agents for colorectal cancer are assessed in rodents. We
speculated that the magnitude of the effect is meaningful and ranked all published agents …